Equities / Sectors / Healthcare
Healthcare
#6 by market capPharmaceuticals, biotechnology, medical devices and care providers. 564 US-listed equities across 10 industries; the sector accounts for 9.3% of tracked equity market cap and 9.8% of daily volume.
Market cap
$7.731T
+0.92%
$70.274B · 1D
Sector weight
9.3%
of tracked market cap
Volume 24h
$45.204B
9.8% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$153.576B
3.7% net margin
P/E (TTM)
50×
Market 30.5×
Dividend yield
1.8%
Market 1.3%
Employees
4.4M
Across 564 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
382.3
Mega caps
7
Median cap
$1.421B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
P/E (TTM): 50× · market 20×
P/S: 1.8× · market 2.7×
EV / EBITDA: 19.3× · market 12.9×
Operating margin: 7.9% · market 8.5%
Dividend yield: 1.8% · market 2.3%
Trading at a 64% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | +0.92% | +0.84% | +0.08% |
| 1 week | -1.55% | +0.64% | -2.19% |
| 1 month | -2.87% | +1.36% | -4.23% |
| 3 months | +1.51% | +2.70% | -1.19% |
| Year to date | +9.31% | +12.65% | -3.34% |
| 1 year | +17.42% | +14.07% | +3.35% |
Constituents
564 equities
Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.02T | 13.2% | $1.14K | +0.11% | -3.33% | -1.38% | $1.568B | 38.2× |
Johnson & Johnson JNJ · US | Drug Manufacturers - General | $609.041B | 7.9% | $252.90 | -1.22% | -6.76% | -8.11% | $1.681B | 29× |
AbbVie Inc. ABBV · US | Drug Manufacturers - General | $469.864B | 6.1% | $265.90 | +1.17% | +0.59% | +1.60% | $1.104B | 75× |
Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $344.621B | 4.5% | $139.54 | -3.30% | -6.21% | -7.98% | $1.05B | 38.6× |
UnitedHealth Group Inc. UNH · US | Healthcare Plans | $342.705B | 4.4% | $378.68 | +1.82% | +0.56% | -5.25% | $1.397B | 24.3× |
Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $251.458B | 3.3% | $676.65 | +3.34% | +0.24% | +11.19% | $1.053B | 36.7× |
Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $217.91B | 2.8% | $403.09 | +0.01% | -2.78% | -8.98% | $793.32M | 24.9× |
Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $179.523B | 2.3% | $144.66 | -0.06% | -4.15% | -3.31% | $418.91M | -55.4× |
Abbott Laboratories ABT · US | Medical Devices | $174.425B | 2.3% | $100.14 | +2.71% | -1.14% | -9.35% | $644.08M | 27.8× |
Pfizer Inc. PFE · US | Drug Manufacturers - General | $156.21B | 2% | $27.41 | -1.40% | -4.40% | -5.55% | $665.79M | 20.9× |
Danaher Corp. DHR · US | Diagnostics & Research | $155.489B | 2% | $221.21 | +3.34% | -1.46% | +5.38% | $568.65M | 38.8× |
Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $143.853B | 1.9% | $406.48 | +3.71% | +0.32% | +9.30% | $670.57M | 45.8× |
| Biotechnology | $127.611B | 1.7% | $503.70 | -0.20% | -4.27% | -9.53% | $232.07M | 29× | |
Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $120.054B | 1.6% | $58.80 | -3.84% | -6.46% | -13.09% | $892.04M | 12.9× |
Medtronic plc MDT · US | Medical Devices | $112.657B | 1.5% | $88.01 | +1.89% | -0.71% | -4.52% | $3.381B | 21.5× |
CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $111.199B | 1.4% | $87.01 | +0.64% | -2.38% | -10.51% | $855.44M | 22.7× |
McKesson Corporation MCK · US | Medical Distribution | $109.945B | 1.4% | $916.21 | +1.54% | +5.72% | -0.93% | $411.78M | 23.1× |
Stryker Corp. SYK · US | Medical Devices | $109.449B | 1.4% | $285.34 | +3.60% | +4.77% | -8.60% | $763.69M | 29.4× |
HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $94.821B | 1.2% | $435.03 | +1.96% | -0.13% | +8.20% | $327.09M | 13.9× |
Elevance Health, Inc. ELV · US | Healthcare Plans | $85.745B | 1.1% | $394.47 | +2.08% | -0.41% | -2.80% | $203.24M | 16.4× |
Moderna Inc. MRNA · US | Biotechnology | $81.081B | 1% | $203.21 | +6.95% | +2.18% | +34.75% | $3.644B | -25.7× |
Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $76.331B | 1% | $726.84 | -1.14% | -7.77% | -14.69% | $375.99M | 17.3× |
The Cigna Group CI · US | Healthcare Plans | $71.537B | 0.9% | $271.35 | +0.30% | -0.24% | -4.06% | $274.3M | 11.2× |
Boston Scientific Corp. BSX · US | Medical Devices | $61.326B | 0.8% | $42.39 | -0.49% | -3.48% | -12.36% | $485.37M | 16.7× |
Natera, Inc. NTRA · US | Diagnostics & Research | $61.128B | 0.8% | $425.65 | +3.73% | +3.17% | +30.90% | $731.51M | -317.8× |